Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2012
07/18/2012CN101711862B Medicine target spot relevant to inflammatory diseases and application thereof
07/18/2012CN101693051B Preparation method and composition of clerodendranthus spicatus extract
07/18/2012CN101554210B A process for decreasing environmental pollutants in an oil or a fat, use of processing fluid and marine oil product
07/18/2012CN101501038B Fused [d]pyridazin-7-ones
07/18/2012CN101490012B Novel crystal of substituted phenylalkanoic acid and production process
07/18/2012CN101475484B Synthesizing method and use of bone-targeted antiphlogistic medicament
07/18/2012CN101389611B Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
07/18/2012CN101328166B 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor
07/18/2012CN101257800B Medicaments containing famotidine and ibuprofen
07/18/2012CN101185868B Technique for preparing lomoxicam ultra-fine particles using by supercritical fluid crystallization technology
07/18/2012CN101124229B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
07/18/2012CN101108224B Plants natural base extractive and formulated product and use thereof
07/17/2012US8222405 Phenylalanine derivatives
07/17/2012US8222277 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/17/2012US8222229 Peritoneal dialysis method
07/17/2012US8221790 Therapeutic polyesters and polyamides
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012US8221737 Hepatitis C virus inhibitors
07/17/2012CA2718348C Orally administered peptides to ameliorate atherosclerosis
07/17/2012CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates
07/17/2012CA2674436C Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
07/17/2012CA2501842C Glucose-based compounds with affinity to p-selectin
07/17/2012CA2496699C Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
07/17/2012CA2451028C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/17/2012CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof
07/17/2012CA2355976C Vascular endothelial cell growth factor antagonists and uses thereof
07/12/2012WO2012094313A1 Pyrazole derivatives as erk inhibitors
07/12/2012WO2012094302A2 Drug delivery using fine fiber encapsulation
07/12/2012WO2012093383A1 Compositions and methods for treatment of sepsis and related conditions
07/12/2012WO2012092880A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS
07/12/2012WO2012092673A1 Bee bloom compositions, methods of extraction and uses thereof
07/12/2012WO2012068454A3 Nrf2 deficiency influences susceptibility to steroid resistance via hdac2 reduction
07/12/2012WO2012062925A3 Compounds and methods for treating pain
07/12/2012WO2012032479A8 1,5-diaryl-2-alkylpyrrole-3-substituted nitro esters, selective cox-2 inhibitors and nitric oxide donors
07/12/2012WO2011116245A3 Methods of treating inflammation
07/12/2012US20120178915 Pyrimidine derivatives and analogs, preparation method and use thereof
07/12/2012US20120178912 RECEPTOR ACTIVATOR OF NF-kappaB
07/12/2012US20120178820 Method for treating arthritis
07/12/2012US20120178809 Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof
07/12/2012US20120178805 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
07/12/2012US20120178778 Pyrazolopyridines
07/12/2012US20120178776 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mglur5 modulators
07/12/2012US20120178766 Furopyrimidinedione derivatives as trpai modulators
07/12/2012US20120178764 Novel Compounds
07/12/2012US20120178759 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
07/12/2012US20120178758 Styryl-triazine derivatives and their therapeutical applications
07/12/2012US20120178752 Rho kinase inhibitors
07/12/2012US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase
07/12/2012US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/12/2012US20120178737 Tricyclic Heterocyclic Compounds as Phosphoinositide 3-Kinase Inhibitors
07/12/2012US20120178736 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
07/12/2012US20120178735 2h-chromene compound and derivative thereof
07/12/2012US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
07/12/2012US20120178730 Sod-imitating metal complexes
07/12/2012US20120178727 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
07/12/2012US20120178724 Compositions for Reducing the Incidence of Drug Induced Arrhythmia
07/12/2012US20120178723 Heteroaryls and uses thereof
07/12/2012US20120178721 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178712 Phytochemical compositions including sesamin for anti-inflammatory, anti-cytokine storm, and other uses
07/12/2012US20120178708 Phenethylsulfone isoindoline derivatives and their use
07/12/2012US20120178706 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside
07/12/2012US20120178704 Prevention and treatment of colon cancer
07/12/2012US20120178703 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof
07/12/2012US20120178695 Methods of treating neuropathic pain
07/12/2012US20120178679 Fused aromatic ptp-ib inhibitors
07/12/2012US20120178670 Acylated glucagon analogues
07/12/2012US20120178668 Proteinaceous compounds and uses therefor
07/12/2012US20120178666 Prodrugs of guanfacine
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177758 Composition comprising turmeric extract and zedoary extract
07/12/2012US20120177756 Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response
07/12/2012US20120177754 Inhibitor of inflammatory conditions
07/12/2012US20120177752 Nutritional compositions including beta-hydroxy-beta-methylbutyrate
07/12/2012US20120177750 Methods for treating pain using topical product formulations containing strontium
07/12/2012US20120177740 Drug delivery formulation for controlling of initial burst and manufacturing method thereof
07/12/2012US20120177739 Delayed Release Tablet with Defined Core Geometry
07/12/2012US20120177738 Green tea extracts of improved bioavailability
07/12/2012US20120177736 Method for treating a patient in need of aspirin therapy
07/12/2012US20120177734 Delayed Release Tablet with Defined Core Geometry
07/12/2012US20120177720 Multi-layer wound dressings
07/12/2012US20120177719 Medical device intended to come into contact with a patient's tissue and related manufacturing method
07/12/2012US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics
07/12/2012US20120177715 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity
07/12/2012US20120177709 Low ph structured surfactant composition
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177702 Solid Forms for Tissue Repair
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177694 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom
07/12/2012US20120177671 Hla-g alpha 1 multimers and pharmaceutical uses thereof
07/12/2012US20120177665 Method of diagnosing and treating interstitial cystitis
07/12/2012US20120177655 Anti-human il-21 monoclonal antibodies
07/12/2012US20120177653 Antibodies that bind both il-17a and il-17f and methods of using the same
07/12/2012US20120177642 Methods of treating inflammatory and autoimmune diseases with natalizumab
07/12/2012US20120177638 Antibodies to vla-1
07/12/2012US20120177616 Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
07/12/2012US20120177600 Compositions and Methods for Inducing or Enhancing Connective Tissue Repair
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
1 ... 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 ... 1272